Biography
Ugur Sahin, born in 1965, is a German medical researcher, entrepreneur, and businessman, and is currently ranked #908 on the Forbes Billionaires list. As the co-founder and CEO of BioNTech, Sahin has significantly impacted the biotechnology industry. His wealth source is rooted in biotechnology, specifically in the development of mRNA-based immunotherapies and vaccines. Sahin's career began in medicine, with a doctorate in cancer immunotherapy, and he later pursued research and academic roles before entering the entrepreneurial world. His most notable achievement is co-developing the first mRNA-based vaccine for COVID-19, with BioNTech's partner Pfizer. He also leads research on cancer vaccines. Sahin's pioneering work has led to several breakthroughs, earning him recognition and awards in the scientific community.
